These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 456975)

  • 1. [Secondary hyperaldosteronism in patients with liver cirrhosis, frequently caused by therapy].
    Spech HJ
    Fortschr Med; 1979 Apr; 97(15):714-8. PubMed ID: 456975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [What role does secondary hyperaldosteronism play in decompensated liver cirrhosis?].
    Albert JP; Hartmann F
    Med Klin; 1981 Jan; 76(3):74-7. PubMed ID: 7219332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The renin-angiotensin-aldosterone system in decompensated cirrhosis: its activity in relation to sodium balance.
    Sellars L; Shore AC; Mott V; Wilkinson R
    Q J Med; 1985 Aug; 56(220):485-96. PubMed ID: 3901077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the activity of the renin-angiotensin-aldosterone system (RAAS) in patients with cirrhosis of the liver.
    Wernze H; Spech HJ; Müller G
    Klin Wochenschr; 1978 Apr; 56(8):389-97. PubMed ID: 642412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Refractory hepatic cirrosis and the ineffectiveness of diuretics in ascites and edema].
    Inoue J; Mori Y; Kawamura T
    Naika; 1969 Nov; 24(5):834-9. PubMed ID: 4902224
    [No Abstract]   [Full Text] [Related]  

  • 6. [Plasma aldosterone and electrolytes in primary and secondard aldosteronism (author's transl)].
    Albert JP; Wronski R; Jentzen F; Hartmann F
    Med Klin; 1979 Sep; 74(37):1315-9. PubMed ID: 492054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Determination of plasma renin activity in edematous cirrhosis. Influence of various depletive treatments].
    Cottin S; Miniconi P; Belet JL; Cadudal JL; Talmant JC; Bailleux A
    Sem Hop; 1973 Apr; 49(19):1357-63. PubMed ID: 4355382
    [No Abstract]   [Full Text] [Related]  

  • 8. Refractory ascites in cirrhosis: roles of volume expansion and plasma atrial natriuretic factor level elevation.
    Wong F; Tobe S; Legault L; Logan AG; Skorecki K; Blendis LM
    Hepatology; 1993 Sep; 18(3):519-28. PubMed ID: 8395457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The renin-angiotensin-aldosterone system in liver cirrhosis].
    Giudici Cipriani A; Folco U; Colombo P; Menardo G; Cattana A; Barbetti V; Rembado R; Marenco G
    Minerva Med; 1990; 81(1-2):45-53. PubMed ID: 2314615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary aldosteronism.
    Corry DB; Tuck ML
    Endocrinol Metab Clin North Am; 1995 Sep; 24(3):511-29. PubMed ID: 8575407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of renin and aldosterone in cirrhotic patients with ascites.
    Rosoff L; Zia P; Reynolds T; Horton R
    Gastroenterology; 1975 Sep; 69(3):698-705. PubMed ID: 1158087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The significance of urine sodium measurement after furosemide administration in diuretics-unresponsive patients with liver cirrhosis].
    Cho HS; Park GT; Kim YH; Shim SG; Kim JB; Lee OY; Choi HS; Hahm JS; Lee MH
    Taehan Kan Hakhoe Chi; 2003 Dec; 9(4):324-31. PubMed ID: 14695699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal hemodynamics and the renin-angiotensin system in cirrhosis.
    Aliaga L; Zozaya JM; Quiroga J; Richter JA; Prieto J
    Rev Esp Fisiol; 1989; 45 Suppl():371-5. PubMed ID: 2701770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naloxone increases water and electrolyte excretion after water loading in patients with cirrhosis and ascites.
    Leehey DJ; Gollapudi P; Deakin A; Reid RW
    J Lab Clin Med; 1991 Nov; 118(5):484-91. PubMed ID: 1940589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular, renal, and neurohumoral responses to single large-volume paracentesis in patients with cirrhosis and diuretic-resistant ascites.
    Peltekian KM; Wong F; Liu PP; Logan AG; Sherman M; Blendis LM
    Am J Gastroenterol; 1997 Mar; 92(3):394-9. PubMed ID: 9068457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathogenesis of ascites formation in liver cirrhosis (author's transl)].
    Arbeiter G; Meyer-Burg J
    Leber Magen Darm; 1974 Oct; 4(6):299-307. PubMed ID: 4373632
    [No Abstract]   [Full Text] [Related]  

  • 17. Interrelationship between atrial natriuretic peptide and plasma renin, aldosterone and catecholamines in hepatic cirrhosis: the effect of passive leg rising.
    Burghardt W; Müller R; Diehl KL; Wernze H
    Z Kardiol; 1988; 77 Suppl 2():104-10. PubMed ID: 2970163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma levels of atrial natriuretic peptide in compensated and decompensated cirrhosis of the liver. Relationship with the renin-aldosterone system.
    Colantonio D; Casale R; Pasqualetti P
    Panminerva Med; 1989; 31(4):166-70. PubMed ID: 2534427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Aldosterone and renin in liver cirrhosis with ascites].
    Vetter H; Vetter W; Beckerhoff R; Glänzer K; Furrer J; Hahn C; Kolloch R; Krück F; Kutz K; Siegenthaler W; Witassek F
    Schweiz Med Wochenschr; 1977 Dec; 107(48):1755-9. PubMed ID: 929137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes of blood pressure, plasma renin activity and plasma aldosterone concentration following the infusion of Sar1-Ile8-angiotensin II in hypertensive, fluid and electrolyte disorders.
    Yamamoto T; Doi K; Ogihara T; Ichihara K; Hata T; Kumahara Y
    Prog Biochem Pharmacol; 1976; 12():174-89. PubMed ID: 1019163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.